Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/17/26 20:19 | 6/17/26 | EW | Health | Orthop | Orthopedic, Prosthetic & Surg | Zovighian Bernard J | CA | DO | CEO | 2 | S.d | -2,879 | 78.08 | 0 | -37 | 115 | I | |||||||||||||||
5/29/26 16:44 | 5/29/26 | EW | Health | Orthop | Orthopedic, Prosthetic & Surg | Dahl Andrew M. | CA | O | SVP,Corp | 1 | S | -49 | 86.01 | 0 | -1 | 15 | D | |||||||||||||||
5/27/26 19:28 | 5/27/26 | EW | Health | Orthop | Orthopedic, Prosthetic & Surg | Bobo Donald E Jr | CA | O | CVP,Stra | 3 | S.d | -5,291 | 82.94 | 0 | -64 | 182 | I | |||||||||||||||
5/22/26 16:35 | 5/22/26 | EW | Health | Orthop | Orthopedic, Prosthetic & Surg | Chopra Daveen | CA | O | CVP,TMTT | 1 | S | -127 | 84.60 | 0 | -2 | 44 | D | |||||||||||||||
5/18/26 17:29 | 5/18/26 | EW | Health | Orthop | Orthopedic, Prosthetic & Surg | Lippis Daniel J. | CA | O | CVP,TAVR | 3 | S.dm | -303 | 82.40 | 0 | -4 | 40 | D | |||||||||||||||
5/11/26 21:33 | 5/11/26 | EW | Health | Orthop | Orthopedic, Prosthetic & Surg | Markowitz Wayne | CA | O | CVP,JAPA | 1 | S.d | -47 | 79.73 | 0 | -1 | 22 | D | |||||||||||||||
4/9/26 19:34 | 4/9/26 | EW | Health | Orthop | Orthopedic, Prosthetic & Surg | Ullem Scott B. | CA | O | CVP,CFO | 1 | S.d | -1,041 | 80.04 | 0 | -13 | 306 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |